JP2013511556A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013511556A5 JP2013511556A5 JP2012540154A JP2012540154A JP2013511556A5 JP 2013511556 A5 JP2013511556 A5 JP 2013511556A5 JP 2012540154 A JP2012540154 A JP 2012540154A JP 2012540154 A JP2012540154 A JP 2012540154A JP 2013511556 A5 JP2013511556 A5 JP 2013511556A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- hydroxybenzenesulfonamide
- halo
- nitro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 28
- 125000001475 halogen functional group Chemical group 0.000 claims 13
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 8
- 125000000217 alkyl group Chemical group 0.000 claims 7
- 150000001875 compounds Chemical class 0.000 claims 7
- 125000004093 cyano group Chemical group *C#N 0.000 claims 7
- -1 N-hydroxylsulfonamidyl Chemical group 0.000 claims 6
- 208000002815 pulmonary hypertension Diseases 0.000 claims 6
- 206010024119 Left ventricular failure Diseases 0.000 claims 4
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims 4
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 claims 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 3
- JTMRAKAVHPQVLR-UHFFFAOYSA-N 2-bromo-n-hydroxybenzenesulfonamide Chemical compound ONS(=O)(=O)C1=CC=CC=C1Br JTMRAKAVHPQVLR-UHFFFAOYSA-N 0.000 claims 2
- QVWABNGSRMHSSC-UHFFFAOYSA-N 2-fluoro-n-hydroxybenzenesulfonamide Chemical compound ONS(=O)(=O)C1=CC=CC=C1F QVWABNGSRMHSSC-UHFFFAOYSA-N 0.000 claims 2
- 208000019622 heart disease Diseases 0.000 claims 2
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 2
- UHLUYTLUWPLQIV-UHFFFAOYSA-N n-hydroxy-2-(trifluoromethyl)benzenesulfonamide Chemical compound ONS(=O)(=O)C1=CC=CC=C1C(F)(F)F UHLUYTLUWPLQIV-UHFFFAOYSA-N 0.000 claims 2
- RPCWSYAQEVLTEE-UHFFFAOYSA-N n-hydroxy-2-iodobenzenesulfonamide Chemical compound ONS(=O)(=O)C1=CC=CC=C1I RPCWSYAQEVLTEE-UHFFFAOYSA-N 0.000 claims 2
- RZRWBKKAFHXNEQ-UHFFFAOYSA-N n-hydroxy-2-methylsulfonylbenzenesulfonamide Chemical compound CS(=O)(=O)C1=CC=CC=C1S(=O)(=O)NO RZRWBKKAFHXNEQ-UHFFFAOYSA-N 0.000 claims 2
- ODUCDPQEXGNKDN-UHFFFAOYSA-N nitroxyl Chemical compound O=N ODUCDPQEXGNKDN-UHFFFAOYSA-N 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- ZRWVFIVDXWDXDB-UHFFFAOYSA-N 2,3-dichloro-n-hydroxybenzenesulfonamide Chemical compound ONS(=O)(=O)C1=CC=CC(Cl)=C1Cl ZRWVFIVDXWDXDB-UHFFFAOYSA-N 0.000 claims 1
- PMCCDTRQTMOMDO-UHFFFAOYSA-N 2,4-dibromo-n-hydroxybenzenesulfonamide Chemical compound ONS(=O)(=O)C1=CC=C(Br)C=C1Br PMCCDTRQTMOMDO-UHFFFAOYSA-N 0.000 claims 1
- XZXRZAJTPROFFJ-UHFFFAOYSA-N 2,4-difluoro-n-hydroxybenzenesulfonamide Chemical compound ONS(=O)(=O)C1=CC=C(F)C=C1F XZXRZAJTPROFFJ-UHFFFAOYSA-N 0.000 claims 1
- NQRQXMMHKBZSFH-UHFFFAOYSA-N 2,6-dichloro-n-hydroxybenzenesulfonamide Chemical compound ONS(=O)(=O)C1=C(Cl)C=CC=C1Cl NQRQXMMHKBZSFH-UHFFFAOYSA-N 0.000 claims 1
- KYAYUXVCXCRWGE-UHFFFAOYSA-N 2-bromo-4-fluoro-n-hydroxybenzenesulfonamide Chemical compound ONS(=O)(=O)C1=CC=C(F)C=C1Br KYAYUXVCXCRWGE-UHFFFAOYSA-N 0.000 claims 1
- KDAUHUPSWREKDU-UHFFFAOYSA-N 2-chloro-4-fluoro-n-hydroxybenzenesulfonamide Chemical compound ONS(=O)(=O)C1=CC=C(F)C=C1Cl KDAUHUPSWREKDU-UHFFFAOYSA-N 0.000 claims 1
- CRGRKPVYYZZUHX-UHFFFAOYSA-N 2-chloro-n-hydroxy-4-(trifluoromethyl)benzenesulfonamide Chemical compound ONS(=O)(=O)C1=CC=C(C(F)(F)F)C=C1Cl CRGRKPVYYZZUHX-UHFFFAOYSA-N 0.000 claims 1
- BASKBTQCHRZHSH-UHFFFAOYSA-N 2-chloro-n-hydroxybenzenesulfonamide Chemical compound ONS(=O)(=O)C1=CC=CC=C1Cl BASKBTQCHRZHSH-UHFFFAOYSA-N 0.000 claims 1
- SNDSZUKNUDOLGZ-UHFFFAOYSA-N 4-bromo-2-chloro-n-hydroxybenzenesulfonamide Chemical compound ONS(=O)(=O)C1=CC=C(Br)C=C1Cl SNDSZUKNUDOLGZ-UHFFFAOYSA-N 0.000 claims 1
- 206010007559 Cardiac failure congestive Diseases 0.000 claims 1
- 208000026151 Chronic thromboembolic pulmonary hypertension Diseases 0.000 claims 1
- 208000003037 Diastolic Heart Failure Diseases 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 206010064911 Pulmonary arterial hypertension Diseases 0.000 claims 1
- 208000008253 Systolic Heart Failure Diseases 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 125000004644 alkyl sulfinyl group Chemical group 0.000 claims 1
- 125000004414 alkyl thio group Chemical group 0.000 claims 1
- 125000003118 aryl group Chemical group 0.000 claims 1
- 125000005163 aryl sulfanyl group Chemical group 0.000 claims 1
- 125000005135 aryl sulfinyl group Chemical group 0.000 claims 1
- 125000004104 aryloxy group Chemical group 0.000 claims 1
- 125000000000 cycloalkoxy group Chemical group 0.000 claims 1
- 125000005171 cycloalkylsulfanyl group Chemical group 0.000 claims 1
- 125000004663 dialkyl amino group Chemical group 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- YWZWWGLSOOIVSN-UHFFFAOYSA-N n-hydroxy-2,4,6-tri(propan-2-yl)benzenesulfonamide Chemical compound CC(C)C1=CC(C(C)C)=C(S(=O)(=O)NO)C(C(C)C)=C1 YWZWWGLSOOIVSN-UHFFFAOYSA-N 0.000 claims 1
- NBJISJHKYNUFIN-UHFFFAOYSA-N n-hydroxy-2,5-bis(trifluoromethyl)benzenesulfonamide Chemical compound ONS(=O)(=O)C1=CC(C(F)(F)F)=CC=C1C(F)(F)F NBJISJHKYNUFIN-UHFFFAOYSA-N 0.000 claims 1
- SEBLDBIKKKKJMQ-UHFFFAOYSA-N n-hydroxy-2-nitro-4-(trifluoromethyl)benzenesulfonamide Chemical compound ONS(=O)(=O)C1=CC=C(C(F)(F)F)C=C1[N+]([O-])=O SEBLDBIKKKKJMQ-UHFFFAOYSA-N 0.000 claims 1
- MGMDZPKSAJJKCS-UHFFFAOYSA-N n-hydroxy-2-phenylbenzenesulfonamide Chemical compound ONS(=O)(=O)C1=CC=CC=C1C1=CC=CC=C1 MGMDZPKSAJJKCS-UHFFFAOYSA-N 0.000 claims 1
- 210000003462 vein Anatomy 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26369809P | 2009-11-23 | 2009-11-23 | |
| US61/263,698 | 2009-11-23 | ||
| US26412909P | 2009-11-24 | 2009-11-24 | |
| US61/264,129 | 2009-11-24 | ||
| PCT/US2010/057844 WO2011063400A1 (en) | 2009-11-23 | 2010-11-23 | Nitroxyl donors for the treatment of pulmonary hypertension |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016015102A Division JP2016128481A (ja) | 2009-11-23 | 2016-01-29 | 肺高血圧症の処置のためのニトロキシル供与体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013511556A JP2013511556A (ja) | 2013-04-04 |
| JP2013511556A5 true JP2013511556A5 (enExample) | 2014-01-16 |
Family
ID=43513876
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012540154A Pending JP2013511556A (ja) | 2009-11-23 | 2010-11-23 | 肺高血圧症の処置のためのニトロキシル供与体 |
| JP2016015102A Pending JP2016128481A (ja) | 2009-11-23 | 2016-01-29 | 肺高血圧症の処置のためのニトロキシル供与体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016015102A Pending JP2016128481A (ja) | 2009-11-23 | 2016-01-29 | 肺高血圧症の処置のためのニトロキシル供与体 |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US20110160200A1 (enExample) |
| EP (1) | EP2504003B1 (enExample) |
| JP (2) | JP2013511556A (enExample) |
| CY (1) | CY1118603T1 (enExample) |
| DK (1) | DK2504003T3 (enExample) |
| ES (1) | ES2611852T3 (enExample) |
| HR (1) | HRP20170183T1 (enExample) |
| HU (1) | HUE032253T2 (enExample) |
| LT (1) | LT2504003T (enExample) |
| PL (1) | PL2504003T3 (enExample) |
| PT (1) | PT2504003T (enExample) |
| RS (1) | RS55697B1 (enExample) |
| SI (1) | SI2504003T1 (enExample) |
| SM (2) | SMT201700090T1 (enExample) |
| WO (2) | WO2011063339A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102753519B (zh) * | 2009-12-07 | 2015-08-05 | 约翰斯霍普金斯大学 | 二酰基化的羟基胺衍生物 |
| CA2782110A1 (en) * | 2009-12-07 | 2011-06-16 | Johns Hopkins University | N-acyloxysulfonamide and n-hydroxy-n-acylsulfonamide derivatives |
| CN104053647B (zh) | 2011-10-17 | 2018-06-01 | 约翰斯霍普金斯大学 | 作为hno供体的经羟胺取代的米氏酸、巴比妥酸和吡唑啉酮衍生物 |
| PL2945620T3 (pl) * | 2013-01-18 | 2018-03-30 | Cardioxyl Pharmaceuticals, Inc. | Donory nitroksylu o korzystniejszym indeksie terapeutycznym |
| AU2014267360B2 (en) * | 2013-05-14 | 2018-07-05 | Active Biotech Ab | N-(heteroaryl)-sulfonamide derivatives useful as S100-inhibitors |
| EP3126329B1 (en) | 2014-01-17 | 2019-05-29 | Cardioxyl Pharmaceuticals Inc. | N-hydroxymethanesulfonamide nitroxyl donors |
| EP3148972B1 (en) | 2014-05-27 | 2019-08-21 | Cardioxyl Pharmaceuticals, Inc. | Pyrazolone derivatives as nitroxyl donors |
| US9464061B2 (en) | 2014-05-27 | 2016-10-11 | The Johns Hopkins University | N-hydroxylamino-barbituric acid derivatives |
| EP3365325A1 (en) | 2015-10-19 | 2018-08-29 | Cardioxyl Pharmaceuticals Inc. | N-hydroxylsulfonamide derivatives as nitroxyl donors |
| EP3365328A1 (en) | 2015-10-19 | 2018-08-29 | Cardioxyl Pharmaceuticals, Inc. | Pyrazolone derivatives as nitroxyl donors |
| KR20190070912A (ko) | 2016-07-28 | 2019-06-21 | 더 존스 홉킨스 유니버시티 | O-치환된 히드록삼산 |
| CA3049003A1 (en) | 2017-01-03 | 2018-07-12 | Cardioxyl Pharmaceuticals, Inc. | Method of administering nitroxyl donating compounds |
Family Cites Families (59)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3219428A (en) * | 1961-04-17 | 1965-11-23 | Hooker Chemical Corp | O,n-diacylated-3,4-dihalophenylhydroxylamines as herbicides |
| US3382243A (en) * | 1965-05-17 | 1968-05-07 | American Home Prod | Acetamides and their preparation |
| US3948967A (en) * | 1968-01-03 | 1976-04-06 | Velsicol Chemical Corporation | Aryl urea carbonates |
| US3661944A (en) * | 1970-07-01 | 1972-05-09 | Smith Kline French Lab | 4-(n-lower alkanoyl)hydroxylamino-4'-aminodiphenylsulfone compounds |
| US3746727A (en) * | 1971-06-07 | 1973-07-17 | Shell Oil Co | Benzenesulfhydroxamic acids and their derivatives |
| US3751255A (en) * | 1972-03-24 | 1973-08-07 | Eastman Kodak Co | Photosensitive and thermosensitive element, composition and process |
| JPS567710A (en) * | 1979-06-28 | 1981-01-27 | Sansho Seiyaku Kk | Whitening cosmetic |
| US4405357A (en) * | 1980-06-02 | 1983-09-20 | Fmc Corporation | Herbicidal 3-isoxazolidinones and hydroxamic acids |
| US4539321A (en) * | 1981-10-26 | 1985-09-03 | William H. Rorer, Inc. | 5-Diaza-aryl-3-substituted pyridone compounds |
| DE3583799D1 (de) * | 1985-01-11 | 1991-09-19 | Abbott Lab Ltd | Feste zubereitung mit langsamer freisetzung. |
| US4663351A (en) * | 1985-08-23 | 1987-05-05 | Berlex Laboratories, Inc. | Dobutamine tri-isobutyric acid ester and the use thereof as a cardiotonic agent |
| US4798824A (en) * | 1985-10-03 | 1989-01-17 | Wisconsin Alumni Research Foundation | Perfusate for the preservation of organs |
| US4954526A (en) * | 1989-02-28 | 1990-09-04 | The United States Of America As Represented By The Department Of Health And Human Services | Stabilized nitric oxide - primary amine complexes useful as cardiovascular agents |
| US5039705A (en) * | 1989-09-15 | 1991-08-13 | The United States Of America As Represented By The Department Of Health And Human Services | Anti-hypertensive compositions of secondary amine-nitric oxide adducts and use thereof |
| US5721365A (en) * | 1989-09-15 | 1998-02-24 | Us Health | N-substituted piperazine NONOates |
| US5212204A (en) * | 1989-10-18 | 1993-05-18 | The United States Of America As Represented By The Department Of Health And Human Services | Antihypertensive compositions and use thereof |
| JP2773959B2 (ja) * | 1990-07-10 | 1998-07-09 | 信越化学工業株式会社 | 大腸内放出性固形製剤 |
| EP0604525A1 (en) * | 1991-09-20 | 1994-07-06 | Zeneca Limited | Enzymatic production of optical isomers of tetrahydropyran-2-ones |
| ES2112332T3 (es) * | 1991-09-24 | 1998-04-01 | Us Health | Derivados de substitucion de oxigeno de productos de adicion de nucleofilo-oxido nitrico utilizados como promedicamentos donadores de oxido nitrico. |
| US5814666A (en) * | 1992-04-13 | 1998-09-29 | The United States As Represented By The Department Of Health And Human Services | Encapsulated and non-encapsulated nitric oxide generators used as antimicrobial agents |
| US5278192A (en) * | 1992-07-02 | 1994-01-11 | The Research Foundation Of State University Of New York | Method of vasodilator therapy for treating a patient with a condition |
| US6200558B1 (en) * | 1993-09-14 | 2001-03-13 | The United States Of America As Represented By The Department Of Health And Human Services | Biopolymer-bound nitric oxide-releasing compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same |
| DK0703902T3 (da) * | 1993-06-24 | 1999-08-23 | Albany Molecular Res Inc | Fremgangsmåde til fremstilling af piperidinderivater |
| JPH09508097A (ja) * | 1993-11-02 | 1997-08-19 | アメリカ合衆国 | 虚血再灌流傷害における保護剤としての酸化窒素放出化合物の使用 |
| US5700830A (en) * | 1994-11-22 | 1997-12-23 | The United States Of America As Represented By The Department Of Health And Human Services | Use of nitric oxide-releasing agents for reducing metastasis risk |
| US6043232A (en) * | 1997-07-23 | 2000-03-28 | Nitromed, Inc. | Nitroso esters of beta-oxo-amides and aryl propionic acid derivatives of non-steroidal antiinflammatory drugs |
| US5703073A (en) * | 1995-04-19 | 1997-12-30 | Nitromed, Inc. | Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs |
| US5674894A (en) * | 1995-05-15 | 1997-10-07 | G.D. Searle & Co. | Amidine derivatives useful as platelet aggregation inhibitors and vasodilators |
| US5714511A (en) * | 1995-07-31 | 1998-02-03 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Selective prevention of organ injury in sepsis and shock using selection release of nitric oxide in vulnerable organs |
| DE19545878A1 (de) * | 1995-12-08 | 1997-06-12 | Basf Ag | Pyridylcarbamate, Verfahren und Zwischenprodukte zu ihrer Herstellung und ihre Verwendung |
| US5824669A (en) * | 1996-03-22 | 1998-10-20 | Nitromed, Inc. | Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders |
| US5958427A (en) * | 1996-11-08 | 1999-09-28 | Salzman; Andrew L. | Nitric oxide donor compounds and pharmaceutical compositions for pulmonary hypertension and other indications |
| TW453999B (en) * | 1997-06-27 | 2001-09-11 | Fujisawa Pharmaceutical Co | Benzimidazole derivatives |
| WO1999021844A1 (en) * | 1997-10-24 | 1999-05-06 | Shionogi & Co., Ltd. | Antirheumatic |
| US6596705B1 (en) * | 1998-02-09 | 2003-07-22 | The Regents Of The University Of California | Inhibition of L-selectin and P-selection mediated binding using heparin |
| UA73092C2 (uk) * | 1998-07-17 | 2005-06-15 | Брістол-Майерс Сквібб Компані | Таблетка з ентеросолюбільним покриттям і спосіб її приготування |
| KR100501022B1 (ko) * | 1998-07-28 | 2005-07-18 | 다나베 세이야꾸 가부시키가이샤 | 장내 적소 방출형 제제 |
| WO2000025776A1 (en) * | 1998-10-30 | 2000-05-11 | Nitromed, Inc. | Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| IL148127A0 (en) * | 1999-08-30 | 2002-09-12 | Aventis Pharma Gmbh | Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events |
| US7045152B2 (en) * | 1999-09-08 | 2006-05-16 | Duke University | Treating pulmonary disorders with gaseous agent causing repletion of GSNO |
| US20010053795A1 (en) * | 2000-06-20 | 2001-12-20 | Bond Richard A. | Paradoxical pharmacology |
| EP1301500B1 (en) * | 2000-06-22 | 2007-11-21 | Nitromed, Inc. | Nitrosated and nitrosylated taxanes, compositions and methods of use |
| US6706724B2 (en) * | 2000-12-21 | 2004-03-16 | Nitromed, Inc. | Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| WO2003006427A1 (en) * | 2001-07-12 | 2003-01-23 | Johns Hopkins University | Compounds that release nitric oxide at controlled rates upon photolysis |
| FR2832634A1 (fr) * | 2001-11-29 | 2003-05-30 | Univ Pasteur | Utilisation des isomeres l de derives aminoacides de l'hydroxyguanidine pour la production de no, compositions pharmaceutiques les contenant et utilisations pharmaceutiques |
| US20040038947A1 (en) * | 2002-06-14 | 2004-02-26 | The Gov. Of The U.S. Of America As Represented By The Sec. Of The Dept. Of Health & Human Services | Method of treating ischemia/reperfusion injury with nitroxyl donors |
| US20040077691A1 (en) * | 2002-06-21 | 2004-04-22 | Medinox, Inc. | Hydroxamate derivatives of non-steroidal anti-inflammatory drugs |
| US6936639B2 (en) | 2002-08-21 | 2005-08-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Nitroxyl progenitors in the treatment of heart failure |
| US20050009789A1 (en) * | 2003-05-13 | 2005-01-13 | The Government Of The Usa As Represented By The Secretary Of The Dept. Of Health And Human Service | Cyclooxygenase inhibition with nitroxyl |
| JP2007514759A (ja) * | 2003-12-19 | 2007-06-07 | タケダ サン ディエゴ インコーポレイテッド | キナーゼ阻害剤 |
| EP1718621A4 (en) | 2004-01-30 | 2009-08-19 | Univ Johns Hopkins | NITROXYL PREPARATION COMPOUNDS APPLICATION METHOD |
| US8168771B2 (en) * | 2005-01-31 | 2012-05-01 | The Johns Hopkins University | Use of consensus sequence as vaccine antigen to enhance recognition of virulent viral variants |
| JP2008543947A (ja) * | 2005-06-23 | 2008-12-04 | ジョンズ ホプキンス ユニバーシティ | チオール感受性の正の変力物質 |
| WO2007045962A2 (en) * | 2005-10-18 | 2007-04-26 | Orchid Research Laboratories Limited | Novel hdac inhibitors |
| PL2489350T3 (pl) * | 2006-03-17 | 2014-08-29 | Cardioxyl Pharmaceuticals Inc | Pochodne N-hydroksylosulfonamidu jako nowe, fizjologicznie użyteczne donory nitroksylu |
| NZ584036A (en) * | 2007-09-26 | 2012-06-29 | Univ Johns Hopkins | N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors |
| US8318705B2 (en) * | 2008-05-07 | 2012-11-27 | Cardioxyl Pharmaceuticals, Inc. | Nitroso compounds as nitroxyl donors and methods of use thereof |
| CA2782110A1 (en) * | 2009-12-07 | 2011-06-16 | Johns Hopkins University | N-acyloxysulfonamide and n-hydroxy-n-acylsulfonamide derivatives |
| CN102753519B (zh) * | 2009-12-07 | 2015-08-05 | 约翰斯霍普金斯大学 | 二酰基化的羟基胺衍生物 |
-
2010
- 2010-11-22 WO PCT/US2010/057640 patent/WO2011063339A1/en not_active Ceased
- 2010-11-22 US US12/951,900 patent/US20110160200A1/en not_active Abandoned
- 2010-11-23 PT PT107844169T patent/PT2504003T/pt unknown
- 2010-11-23 EP EP10784416.9A patent/EP2504003B1/en active Active
- 2010-11-23 ES ES10784416.9T patent/ES2611852T3/es active Active
- 2010-11-23 WO PCT/US2010/057844 patent/WO2011063400A1/en not_active Ceased
- 2010-11-23 JP JP2012540154A patent/JP2013511556A/ja active Pending
- 2010-11-23 DK DK10784416.9T patent/DK2504003T3/en active
- 2010-11-23 SM SM20170090T patent/SMT201700090T1/it unknown
- 2010-11-23 PL PL10784416T patent/PL2504003T3/pl unknown
- 2010-11-23 HU HUE10784416A patent/HUE032253T2/en unknown
- 2010-11-23 SI SI201031332A patent/SI2504003T1/sl unknown
- 2010-11-23 LT LTEP10784416.9T patent/LT2504003T/lt unknown
- 2010-11-23 RS RS20170138A patent/RS55697B1/sr unknown
- 2010-11-23 HR HRP20170183TT patent/HRP20170183T1/hr unknown
-
2015
- 2015-04-24 US US14/696,319 patent/US20160081951A1/en not_active Abandoned
-
2016
- 2016-01-29 JP JP2016015102A patent/JP2016128481A/ja active Pending
-
2017
- 2017-02-07 CY CY20171100169T patent/CY1118603T1/el unknown
- 2017-02-09 SM SM201700090T patent/SMT201700090B/it unknown